Identification of Tissue miRNA Signatures for Pancreatic Ductal Adenocarcinoma
Carlo Caputo(University of Campania "Luigi Vanvitelli"), Gabriella Misso(University of Campania "Luigi Vanvitelli"), Antonio Cossu(Istituto di Chimica Biomolecolare), Margherita Maioli(University of Sassari), Chiara Carmen Miceli(University of Campania "Luigi Vanvitelli"), Anna Grimaldi(University of Campania "Luigi Vanvitelli"), Giovanni Conzo(University of Campania "Luigi Vanvitelli"), Angela Lombardi(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Luca Pompella(University of Campania "Luigi Vanvitelli"), Antonio Fico, Fortunato Ciardiello(University of Naples Federico II), Chiara Tammaro(University of Campania "Luigi Vanvitelli"), Michela Falco(University of Campania "Luigi Vanvitelli"), Giuseppe Tirino(University of Campania "Luigi Vanvitelli"), Donatella Coradduzza(University of Sassari), Alessandro Ottaiano(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Michele Caraglia(University of Campania "Luigi Vanvitelli"), Severo Campione(Federico II University Hospital), Mariateresa Cocule(University of Campania "Luigi Vanvitelli"), Marco Montella(University of Campania "Luigi Vanvitelli"), Giovanni Savarese(Regione Campania), Madhura S. Tathode(University of Campania "Luigi Vanvitelli"), G. Pintori(University of Sassari), Ferdinando De Vita(University of Campania "Luigi Vanvitelli")
Cited by 6
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
|The Lancet|2016|4.8k
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer
|New England Journal of Medicine|2019|1.5k